The opening of a new trial in Missouri marks a significant moment in the ongoing legal battles over Monsanto’s herbicide, Roundup. This case, representing the first of its kind since a key U.S. Supreme Court decision, sees three Florida women alleging that their non-Hodgkin lymphoma diagnoses were caused by exposure to the widely used weed killer. Greg Dovel from Dovel & Luner represents the plaintiffs, emphasizing the contention that Monsanto failed to adequately test the safety of its product. More information about the trial can be found here.
The trial comes on the heels of the Supreme Court’s decision not to review a previous verdict that awarded $25 million to a Californian man who argued his cancer was linked to Roundup. This refusal put the focus back on Monsanto’s parent company, Bayer, to navigate through a slew of pending lawsuits across the United States. The legal conversation frequently grapples with studies claiming glyphosate, the active ingredient in Roundup, is carcinogenic, a stance supported by the International Agency for Research on Cancer, yet challenged by U.S. Environmental Protection Agency consensus that it is not likely to cause cancer.
Bayer continues to maintain that extensive research backs the safety of glyphosate-based products when used as directed, evident in their strategy to settle thousands of cases even as litigation advances. The company faces mounting pressure to balance the financial and reputational impact stemming from these lawsuits.
This Missouri trial is particularly pivotal as it could set precedents for future litigation. The plaintiffs allege that Monsanto’s testing procedures were inadequate, potentially disregarding risks related to prolonged exposure. The outcomes of these trials could impact not just corporate policies but also regulatory standards, influencing how companies defend their product safety in court.
As the trial unfolds, legal professionals and corporate entities alike will be watching closely, recognizing the implications for both consumer protection and corporate accountability in the agribusiness sector. The broader legal community will be keenly attuned to the strategies employed by both sides as they predict how this might shape future rounds in this prolonged legal saga.